Ben Tarver’s night terrors were the first symptoms of Anti-NMDA Receptor Encephalitis, a rare autoimmune disorder that landed him in the ICU Cara Lynn Shultz is a writer-reporter at PEOPLE.
Palleon Pharmaceuticals and Shanghai Henlius Biotech have entered a licence agreement and partnership for the former’s sialidase enzyme therapeutic, E-602, to treat autoimmune diseases.